Table 1.
Hemodynamic assessments of control and SM22α-ET-1−/− mice
Normoxia |
Chronic Hypoxia |
|||
---|---|---|---|---|
Control | SM22α-ET-1−/− | Control | SM22α-ET-1−/− | |
Hematocrit, % | 44.2 ± 0.8 (6) | 42.0 ± 2.1 (4) | 54.2 ± 0.6† (3) | 56.3 ± 3.2* (3) |
Heart rate, beats/min | 367 ± 31 (3) | 373 ± 10.7 (4) | 411 ± 16.7* (6) | 419 ± 9.9* (4) |
Body weight, g | 28.8 ± 1.3 (12) | 30.9 ± 1.2 (10) | 25.3 ± 2.3* (5) | 27.3 ± 2.3* (5) |
Left ventricular fractional shortening, % | 30.0 ± 3.7 (3) | 30.0 ± 3.9 (4) | 34.5 ± 0.7 (5) | 30.8 ± 1.9 (4) |
Aortic valve velocity time integral, cm | 2.45 ± 0.3 (3) | 2.84 ± 0.5 (4) | 2.6 ± 0.3 (5) | 2.35 ± 0.3 (4) |
Values are expressed as means ± SE; numbers of mice per group are in parentheses.
P < 0.05,
P < 0.001, hypoxia vs. normoxia. ET-1, endothelin-1.